Expression of Concern: Gefitinib (Iressa) Represses FOXM1 Expression via FOXO3a in Breast Cancer
The veracity of the findings in this article is in question due to apparent instances of western blot duplication and irregularities.Specifically, the first four panels of actin bands in Fig. 2A
Authors
- Jimmy M-M. Kwok
- Ursula McGovern (ORCID: https://orcid.org/0000-0001-9412-4028)
- Stephen S. Myatt
- W-F Lam Eric
- Stephanie K. Guest
- Janna Krol
- Andreas Polychronis
- Barrie Peck (ORCID: https://orcid.org/0000-0002-6687-8495)
- Jun Wang (ORCID: https://orcid.org/0000-0003-4513-6561)
- Richard E. Francis
- R. Charles Coombes
Institutions
- Cancer Research Center (US)
Publication Details
- Journal
- Molecular Cancer Therapeutics
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1158/1535-7163.mct-26-0153
- Primary Topic
- FOXO transcription factor regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00